Semiconductors
Compare Stocks
5 / 10Stock Comparison
IPGP vs NOVT vs MKSI vs CGNX vs ONTO
Revenue, margins, valuation, and 5-year total return — side by side.
Hardware, Equipment & Parts
Hardware, Equipment & Parts
Hardware, Equipment & Parts
Semiconductors
IPGP vs NOVT vs MKSI vs CGNX vs ONTO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Hardware, Equipment & Parts | Hardware, Equipment & Parts | Hardware, Equipment & Parts | Semiconductors |
| Market Cap | $4.31B | $4.86B | $20.25B | $11.01B | $13.63B |
| Revenue (TTM) | $1.04B | $981M | $4.07B | $1.05B | $1.03B |
| Net Income (TTM) | $29M | $54M | $327M | $143M | $106M |
| Gross Margin | 37.6% | 44.4% | 45.2% | 68.0% | 48.8% |
| Operating Margin | 0.3% | 11.9% | 14.8% | 18.8% | 10.0% |
| Forward P/E | 62.6x | 38.2x | 30.4x | 53.0x | 38.7x |
| Total Debt | $0.00 | $342M | $4.69B | $77M | $17M |
| Cash & Equiv. | $404M | $381M | $675M | $263M | $346M |
IPGP vs NOVT vs MKSI vs CGNX vs ONTO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| IPG Photonics Corpo… (IPGP) | 100 | 65.4 | -34.6% |
| Novanta Inc. (NOVT) | 100 | 132.7 | +32.7% |
| MKS Inc. (MKSI) | 100 | 284.8 | +184.8% |
| Cognex Corporation (CGNX) | 100 | 116.2 | +16.2% |
| Onto Innovation Inc. (ONTO) | 100 | 881.7 | +781.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IPGP vs NOVT vs MKSI vs CGNX vs ONTO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IPGP plays a supporting role in this comparison — it may shine differently against other peers.
NOVT lags the leaders in this set but could rank higher in a more targeted comparison.
MKSI is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 9.6%, EPS growth 55.5%, 3Y rev CAGR 3.5%
- 9.6% revenue growth vs ONTO's 1.8%
- Lower P/E (30.4x vs 53.0x)
- +306.1% vs NOVT's +14.6%
CGNX carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 4 yrs, beta 1.50, yield 0.5%
- Lower volatility, beta 1.50, Low D/E 5.1%, current ratio 3.80x
- Beta 1.50, yield 0.5%, current ratio 3.80x
- 13.6% margin vs IPGP's 2.8%
ONTO is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 14.3% 10Y total return vs NOVT's 8.5%
- PEG 1.12 vs NOVT's 11.61
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 9.6% revenue growth vs ONTO's 1.8% | |
| Value | Lower P/E (30.4x vs 53.0x) | |
| Quality / Margins | 13.6% margin vs IPGP's 2.8% | |
| Stability / Safety | Beta 1.50 vs ONTO's 2.66 | |
| Dividends | 0.5% yield, 4-year raise streak, vs MKSI's 0.3%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +306.1% vs NOVT's +14.6% | |
| Efficiency (ROA) | 7.1% ROA vs IPGP's 1.2%, ROIC 9.0% vs 0.6% |
IPGP vs NOVT vs MKSI vs CGNX vs ONTO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IPGP vs NOVT vs MKSI vs CGNX vs ONTO — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CGNX leads in 3 of 6 categories
MKSI leads 2 • IPGP leads 0 • NOVT leads 0 • ONTO leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CGNX leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MKSI is the larger business by revenue, generating $4.1B annually — 4.2x NOVT's $981M. CGNX is the more profitable business, keeping 13.6% of every revenue dollar as net income compared to IPGP's 2.8%. On growth, CGNX holds the edge at +24.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.0B | $981M | $4.1B | $1.0B | $1.0B |
| EBITDAEarnings before interest/tax | $55M | $179M | $945M | $219M | $158M |
| Net IncomeAfter-tax profit | $29M | $54M | $327M | $143M | $106M |
| Free Cash FlowCash after capex | $8M | $48M | $401M | $241M | $239M |
| Gross MarginGross profit ÷ Revenue | +37.6% | +44.4% | +45.2% | +68.0% | +48.8% |
| Operating MarginEBIT ÷ Revenue | +0.3% | +11.9% | +14.8% | +18.8% | +10.0% |
| Net MarginNet income ÷ Revenue | +2.8% | +5.5% | +8.0% | +13.6% | +10.3% |
| FCF MarginFCF ÷ Revenue | +0.8% | +4.9% | +9.8% | +23.0% | +23.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +16.6% | +8.5% | +15.2% | +24.3% | +9.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -54.4% | -2.2% | +53.2% | +121.4% | -48.5% |
Valuation Metrics
MKSI leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 68.8x trailing earnings, MKSI trades at a 51% valuation discount to IPGP's 139.2x P/E. Adjusting for growth (PEG ratio), ONTO offers better value at 2.85x vs NOVT's 28.13x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4.3B | $4.9B | $20.2B | $11.0B | $13.6B |
| Enterprise ValueMkt cap + debt − cash | $3.9B | $4.8B | $24.3B | $10.8B | $13.3B |
| Trailing P/EPrice ÷ TTM EPS | 139.22x | 92.71x | 68.83x | 96.92x | 98.57x |
| Forward P/EPrice ÷ next-FY EPS est. | 62.62x | 38.25x | 30.36x | 53.05x | 38.74x |
| PEG RatioP/E ÷ EPS growth rate | — | 28.13x | — | — | 2.85x |
| EV / EBITDAEnterprise value multiple | 48.90x | 27.00x | 26.70x | 55.96x | 68.79x |
| Price / SalesMarket cap ÷ Revenue | 4.30x | 4.96x | 5.15x | 11.07x | 13.56x |
| Price / BookPrice ÷ Book value/share | 2.04x | 3.81x | 7.49x | 7.48x | 6.43x |
| Price / FCFMarket cap ÷ FCF | — | 100.38x | 40.74x | 46.49x | 45.47x |
Profitability & Efficiency
CGNX leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
MKSI delivers a 12.2% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $1 for IPGP. ONTO carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to MKSI's 1.73x. On the Piotroski fundamental quality scale (0–9), CGNX scores 7/9 vs ONTO's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.4% | +4.1% | +12.2% | +9.6% | +5.2% |
| ROA (TTM)Return on assets | +1.2% | +3.0% | +3.7% | +7.1% | +4.7% |
| ROICReturn on invested capital | +0.6% | +7.4% | +6.5% | +9.0% | +5.7% |
| ROCEReturn on capital employed | +0.6% | +8.3% | +7.2% | +8.9% | +6.5% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 6 | 7 | 4 |
| Debt / EquityFinancial leverage | — | 0.26x | 1.73x | 0.05x | 0.01x |
| Net DebtTotal debt minus cash | -$404M | -$39M | $4.0B | -$186M | -$329M |
| Cash & Equiv.Liquid assets | $404M | $381M | $675M | $263M | $346M |
| Total DebtShort + long-term debt | $0 | $342M | $4.7B | $77M | $17M |
| Interest CoverageEBIT ÷ Interest expense | — | 4.89x | 2.84x | — | — |
Total Returns (Dividends Reinvested)
MKSI leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ONTO five years ago would be worth $41,263 today (with dividends reinvested), compared to $5,151 for IPGP. Over the past 12 months, MKSI leads with a +306.1% total return vs NOVT's +14.6%. The 3-year compound annual growth rate (CAGR) favors MKSI at 54.1% vs NOVT's -5.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +35.8% | +22.6% | +78.8% | +78.7% | +65.2% |
| 1-Year ReturnPast 12 months | +75.6% | +14.6% | +306.1% | +133.1% | +118.9% |
| 3-Year ReturnCumulative with dividends | -12.7% | -15.2% | +266.0% | +34.7% | +218.0% |
| 5-Year ReturnCumulative with dividends | -48.5% | +5.7% | +66.5% | -13.2% | +312.6% |
| 10-Year ReturnCumulative with dividends | +20.2% | +853.7% | +750.6% | +249.6% | +1431.7% |
| CAGR (3Y)Annualised 3-year return | -4.4% | -5.3% | +54.1% | +10.4% | +47.1% |
Risk & Volatility
Evenly matched — MKSI and CGNX each lead in 1 of 2 comparable metrics.
Risk & Volatility
CGNX is the less volatile stock with a 1.50 beta — it tends to amplify market swings less than ONTO's 2.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MKSI currently trades 92.0% from its 52-week high vs IPGP's 65.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.80x | 2.02x | 2.64x | 1.50x | 2.66x |
| 52-Week HighHighest price in past year | $155.82 | $149.95 | $326.83 | $71.90 | $315.86 |
| 52-Week LowLowest price in past year | $53.98 | $98.27 | $71.49 | $27.82 | $85.88 |
| % of 52W HighCurrent price vs 52-week peak | +65.2% | +90.9% | +92.0% | +91.7% | +86.8% |
| RSI (14)Momentum oscillator 0–100 | 39.7 | 62.6 | 65.3 | 76.3 | 61.0 |
| Avg Volume (50D)Average daily shares traded | 510K | 375K | 1.2M | 2.0M | 832K |
Analyst Outlook
CGNX leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: IPGP as "Buy", NOVT as "Buy", MKSI as "Buy", CGNX as "Hold", ONTO as "Buy". Consensus price targets imply 49.2% upside for IPGP (target: $152) vs -9.3% for MKSI (target: $273). For income investors, CGNX offers the higher dividend yield at 0.49% vs MKSI's 0.29%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $151.67 | $150.00 | $272.86 | $60.22 | $308.33 |
| # AnalystsCovering analysts | 27 | 3 | 29 | 31 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.3% | +0.5% | — |
| Dividend StreakConsecutive years of raises | 1 | — | 0 | 4 | — |
| Dividend / ShareAnnual DPS | — | — | $0.87 | $0.32 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.3% | +0.8% | +0.2% | +1.4% | +0.6% |
CGNX leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MKSI leads in 2 (Valuation Metrics, Total Returns). 1 tied.
IPGP vs NOVT vs MKSI vs CGNX vs ONTO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IPGP or NOVT or MKSI or CGNX or ONTO a better buy right now?
For growth investors, MKS Inc.
(MKSI) is the stronger pick with 9. 6% revenue growth year-over-year, versus 1. 8% for Onto Innovation Inc. (ONTO). MKS Inc. (MKSI) offers the better valuation at 68. 8x trailing P/E (30. 4x forward), making it the more compelling value choice. Analysts rate IPG Photonics Corporation (IPGP) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IPGP or NOVT or MKSI or CGNX or ONTO?
On trailing P/E, MKS Inc.
(MKSI) is the cheapest at 68. 8x versus IPG Photonics Corporation at 139. 2x. On forward P/E, MKS Inc. is actually cheaper at 30. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Onto Innovation Inc. wins at 1. 12x versus Novanta Inc. 's 11. 61x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — IPGP or NOVT or MKSI or CGNX or ONTO?
Over the past 5 years, Onto Innovation Inc.
(ONTO) delivered a total return of +312. 6%, compared to -48. 5% for IPG Photonics Corporation (IPGP). Over 10 years, the gap is even starker: ONTO returned +1432% versus IPGP's +20. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IPGP or NOVT or MKSI or CGNX or ONTO?
By beta (market sensitivity over 5 years), Cognex Corporation (CGNX) is the lower-risk stock at 1.
50β versus Onto Innovation Inc. 's 2. 66β — meaning ONTO is approximately 77% more volatile than CGNX relative to the S&P 500. On balance sheet safety, Onto Innovation Inc. (ONTO) carries a lower debt/equity ratio of 1% versus 173% for MKS Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IPGP or NOVT or MKSI or CGNX or ONTO?
By revenue growth (latest reported year), MKS Inc.
(MKSI) is pulling ahead at 9. 6% versus 1. 8% for Onto Innovation Inc. (ONTO). On earnings-per-share growth, the picture is similar: IPG Photonics Corporation grew EPS 117. 8% year-over-year, compared to -31. 5% for Onto Innovation Inc.. Over a 3-year CAGR, NOVT leads at 4. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IPGP or NOVT or MKSI or CGNX or ONTO?
Onto Innovation Inc.
(ONTO) is the more profitable company, earning 13. 6% net margin versus 3. 1% for IPG Photonics Corporation — meaning it keeps 13. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CGNX leads at 16. 3% versus 1. 3% for IPGP. At the gross margin level — before operating expenses — CGNX leads at 66. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IPGP or NOVT or MKSI or CGNX or ONTO more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Onto Innovation Inc. (ONTO) is the more undervalued stock at a PEG of 1. 12x versus Novanta Inc. 's 11. 61x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, MKS Inc. (MKSI) trades at 30. 4x forward P/E versus 62. 6x for IPG Photonics Corporation — 32. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IPGP: 49. 2% to $151. 67.
08Which pays a better dividend — IPGP or NOVT or MKSI or CGNX or ONTO?
In this comparison, CGNX (0.
5% yield), MKSI (0. 3% yield) pay a dividend. IPGP, NOVT, ONTO do not pay a meaningful dividend and should not be held primarily for income.
09Is IPGP or NOVT or MKSI or CGNX or ONTO better for a retirement portfolio?
For long-horizon retirement investors, Onto Innovation Inc.
(ONTO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1432% 10Y return). IPG Photonics Corporation (IPGP) carries a higher beta of 1. 80 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ONTO: +1432%, IPGP: +20. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IPGP and NOVT and MKSI and CGNX and ONTO?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.